Page last updated: 2024-09-03

valdecoxib and Dysmenorrhea

valdecoxib has been researched along with Dysmenorrhea in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daniels, SE; Recker, DP; Snabes, MC; Talwalker, S; Torri, S; Verburg, KM	1
Ormrod, D; Wagstaff, AJ; Wellington, K	1
Hayes, EC; Rock, JA	1
Alsalameh, S; Burian, M; Geisslinger, G; Mahr, G; Woodcock, BG	1
Chavez, ML; DeKorte, CJ	1
Fenton, C; Keating, GM; Wagstaff, AJ	1
Malaise, M; Scheen, AJ	1
Daniels, SE; Desjardins, PJ; Torri, S	1
FitzGerald, GA	1

Reviews

6 review(s) available for valdecoxib and Dysmenorrhea

Article	Year
Valdecoxib. Drugs, 2002, Volume: 62, Issue:14 Topics: Arthritis; Clinical Trials as Topic; Dysmenorrhea; Female; Humans; Isoxazoles; Pain; Sulfonamides	2002
COX-2 inhibitors and their role in gynecology. Obstetrical & gynecological survey, 2002, Volume: 57, Issue:11 Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Administration Schedule; Dysmenorrhea; Endometriosis; Female; Genital Diseases, Female; Humans; Infertility, Female; Isoenzymes; Isoxazoles; Labor, Obstetric; Membrane Proteins; Menorrhagia; Menstrual Cycle; Ovary; Ovulation; Pain; Polycystic Ovary Syndrome; Pregnancy; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides	2002
Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor. Alimentary pharmacology & therapeutics, 2003, Feb-15, Volume: 17, Issue:4 Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Availability; Bone Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Dysmenorrhea; Female; Humans; Isoenzymes; Isoxazoles; Liver Diseases; Male; Membrane Proteins; Middle Aged; Mouth Diseases; Osteoarthritis; Pain; Prostaglandin-Endoperoxide Synthases; Rats; Sulfonamides	2003
Valdecoxib: a review. Clinical therapeutics, 2003, Volume: 25, Issue:3 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Dysmenorrhea; Enzyme Inhibitors; Female; Humans; Isoxazoles; Male; Osteoarthritis; Pain, Postoperative; Sulfonamides; Treatment Outcome	2003
Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. Drugs, 2004, Volume: 64, Issue:11 Topics: Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Drug Interactions; Dysmenorrhea; Female; Half-Life; Humans; Intestinal Absorption; Isoxazoles; Male; Osteoarthritis; Pain, Postoperative; Randomized Controlled Trials as Topic; Sulfonamides; Tissue Distribution; Treatment Outcome	2004
[Valdecoxib (Bextra)]. Revue medicale de Liege, 2004, Volume: 59, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Dysmenorrhea; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Isoxazoles; Osteoarthritis; Pain, Postoperative; Prodrugs; Sulfonamides	2004

Trials

2 trial(s) available for valdecoxib and Dysmenorrhea

Article	Year
Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. Obstetrics and gynecology, 2002, Volume: 100, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Cross-Over Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dysmenorrhea; Female; Humans; Isoxazoles; Naproxen; Pain Measurement; Probability; Reference Values; Sulfonamides; Treatment Outcome	2002
Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen. Journal of general internal medicine, 2005, Volume: 20, Issue:1 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Dysmenorrhea; Female; Humans; Isoxazoles; Naproxen; Sulfonamides; Treatment Outcome	2005

Article

Year

Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea.

Obstetrics and gynecology, 2002, Volume: 100, Issue:2

Topics: Administration, Oral; Adolescent; Adult; Cross-Over Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dysmenorrhea; Female; Humans; Isoxazoles; Naproxen; Pain Measurement; Probability; Reference Values; Sulfonamides; Treatment Outcome

2002

Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.

Journal of general internal medicine, 2005, Volume: 20, Issue:1

Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Dysmenorrhea; Female; Humans; Isoxazoles; Naproxen; Sulfonamides; Treatment Outcome

2005

Other Studies

1 other study(ies) available for valdecoxib and Dysmenorrhea

Article	Year
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach. The American journal of cardiology, 2002, Mar-21, Volume: 89, Issue:6A Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular System; Celecoxib; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Isoxazoles; Lactones; Male; Pyrazoles; Sulfonamides; Sulfones	2002

Article

Year

Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach.

The American journal of cardiology, 2002, Mar-21, Volume: 89, Issue:6A

Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular System; Celecoxib; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Isoxazoles; Lactones; Male; Pyrazoles; Sulfonamides; Sulfones

2002